Johnson & Johnson Covid vaccine could weigh o...

The race to succeed JPMorgan Chase chief executive Jamie Dimon just got tighter, and the investment chief at insurance group Allianz is warning that the SpaceX bond sale signals markets are in ‘bubble territory’. Plus, the US Supreme Court shielded German pharmaceuticals group Ba ...  Show more

Anthropic accuses Alibaba of obtaining ‘illicit’ access to Claude, and concern is brewing over KNDS’s upcoming initial public offering after Germany scraps warship plans. Plus, Meta is turning to AI content moderators, and the FT’s John Plender breaks down Donald Trump’s contribu ...  Show more

Dr. Bob calls up Dr. Julie Gerberding to address vaccines, the CDC, and how public trust factors into both. Julie has vast experience with all of those topics, having served as president of Merck vaccines and also as CDC director under George W. Bush, the first woman to serve in ...  Show more

Federal health agencies on Tuesday called for a pause in the use of Johnson & Johnson’s coronavirus shot as they examine a rare blood-clotting disorder that emerged in six recipients.

Every state, the District of Columbia and Puerto Rico halted their rollout of the Johns ...

Garrison Davis is joined by Robert Evans to discuss Covid Vaccine Grifters.

Footnotes:

The FDA meets this week to discuss boosters for the Moderna and Johnson & Johnson vaccines, and the efficacy of mixing boosters from different vaccine brands. Later, President Biden speaks from the White House on the significant progress America has made in tackling Covid-19, and ...  Show more